Schizophrenia Risk Influenced by Paternal Age
the Psychiatry Advisor take:
Children who are born to an older father are at a much higher risk of developing a schizophrenia spectrum disorder, according to a new study.
Holger Sørensen, PhD, of Copenhagen University Hospital, Bispebjerg, Denmark, and colleagues examined data on nearly 139,000 Danish men born between 1955 and 1984, and between 1976 and 1993.
The risk of developing schizophrenia increases by 32% in young adults for each 10-year increase in their father’s age at birth, the researchers reported in the journal Schizophrenia Research. Men born to fathers 45 years or older had a fully adjusted incidence rate ratio for a schizophrenia spectrum disorder of 1.89, compared with men born to fathers aged 25–29 years.
However, the same study showed that having an older father did not influence the child’s premorbid IQ. The unadjusted incidence rate ratio per standard deviation (SD) increase in IQ score was 0.68, and 0.69 after ages of the parents had been taken into account.
Interestingly, a higher IQ diminished the risk of a schizophrenia diagnosis. Each SD increase in IQ decreased the schizophrenia risk by 30%, irrespective of the age of the father at birth.
“The psychosocial benefits of having an older parent influence the premorbid general cognitive ability in persons who were on the path to develop a disorder in the schizophrenia spectrum,” the researchers concluded.
Some of those benefits include the likelihood of having a planned pregnancy, having parents with a better educational and socioeconomic status, and having stable home environments, they added.
Mild Cognitive Impairment Greatly Boosts Alzheimer's, Dementia Risk
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Transference in the Age of #MeToo: What Counts as Harassment From a Patient?
- Should Physicians Treat Family and Friends? Three Experts Weigh In
- Predictors of Long-term Medication Adherence in Children With ADHD
- Influence of Psychostimulants on BMI and Height in Youth With ADHD
- Medication Adherence Predictors in Patients With Severe Psychiatric Disorders
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Substance Abuse and Primary Psychosis: A Closer Look
- Functional Restoration for Chronic Pain and Depression in the Elderly: Pharmacotherapy and Beyond
- Efficacy of Long-Acting Injectable Antipsychotics vs Oral Antipsychotics
- Older Age Associated With Worse Major Depressive Disorder Outcomes
- Preoperative Psychiatric Diagnoses Not Associated With Bariatric Surgery Outcomes
- Medical Clearance of Psych Patients in the ED: Consensus Recommendations